<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> presents with vascular malformations of the brain, skin, and eye </plain></SENT>
<SENT sid="1" pm="."><plain>Fibronectin has potent effects on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, vessel remodeling, and vessel innervation density </plain></SENT>
<SENT sid="2" pm="."><plain>To determine fibronectin expression in the blood vessels of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> brain and skin tissue and to quantify the density and circumference of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> blood vessels by type compared with controls, we performed in situ hybridization for fibronectin messenger <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> (<z:chebi fb="40" ids="33697">RNA</z:chebi>) expression on six <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> cortical brain samples, six <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> brain samples, skin from two <z:hpo ids='HP_0001052'>port-wine stain</z:hpo> <z:mp ids='MP_0001212'>skin lesions</z:mp>, and two <z:mpath ids='MPATH_458'>normal</z:mpath> skin samples from two subjects with <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Fibronectin <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> was expressed in blood vessels and endothelial cells in the parenchyma of both <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> and control brain tissues and in skin samples </plain></SENT>
<SENT sid="4" pm="."><plain>Fibronectin expression was significantly reduced by 23% in the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> meningeal vessels compared with the <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> controls (P &lt; .01) </plain></SENT>
<SENT sid="5" pm="."><plain>Fibronectin expression was significantly increased by 19% in the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> parenchymal vessels compared with the <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> controls (P &lt; .05) </plain></SENT>
<SENT sid="6" pm="."><plain>No difference was found in the expression of fibronectin in <z:hpo ids='HP_0001052'>port-wine stain</z:hpo> skin blood vessels </plain></SENT>
<SENT sid="7" pm="."><plain>The density of leptomeningeal blood vessels in the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> brain tissue samples was 45% greater than in the <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> samples (P &lt; .05) </plain></SENT>
<SENT sid="8" pm="."><plain>Blood vessel circumference was significantly decreased in the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> meningeal vessels compared with the controls (27%; P &lt; .05) </plain></SENT>
<SENT sid="9" pm="."><plain>When blood vessels from different brain regions were compared, fibronectin expression was decreased in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> meningeal vessels and was increased in the parenchymal vessels </plain></SENT>
<SENT sid="10" pm="."><plain>Altered blood vessel fibronectin expression in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> could contribute to abnormal vascular structure and function in this disorder </plain></SENT>
</text></document>